March 5 (Bloomberg) -- Elsa Sung, chief financial officer at Genesis Pharmaceuticals Enterprises Inc., talks with Bloomberg's Bernard Lo about the impact of China's stimulus package on Genesis and the outlook for China's pharmaceutical industry. (This is an excerpt. Source: Bloomberg)

Running time 01:23

-0- Mar/05/2009 01:59 GMT

Last Updated: March 4, 2009 20:59 EST